Commentary: APP As a Mediator of the Synapse Pathology in Alzheimer's Disease

Overview

Journal Front Cell Neurosci

Specialty Cell Biology

Date 2018 Jun 16

PMID 29905239

Citations 2

Authors

An Schreurs

Amira Latif-Hernandez

Alice Uwineza

Affiliations

Soon will be listed here.

Citing Articles

Ameliorating Alzheimer's-like Pathology by Minocycline via Inhibiting Cdk5/p25 Signaling.

Zhao Y, Wang C, He W, Cai Z Curr Neuropharmacol. 2021; 20(9):1783-1792.

PMID: 34856907 PMC: 9881058. DOI: 10.2174/1570159X19666211202124925.

Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer's disease models.

Corsetti V, Borreca A, Latina V, Giacovazzo G, Pignataro A, Krashia P Brain Commun. 2020; 2(1):fcaa039.

PMID: 32954296 PMC: 7425324. DOI: 10.1093/braincomms/fcaa039.

References

Ferreira S, Lourenco M, Oliveira M, De Felice F . Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease. Front Cell Neurosci. 2015; 9:191. PMC: 4443025. DOI: 10.3389/fncel.2015.00191. View

Callahan D, Taylor W, Tilearcio M, Cavanaugh T, Selkoe D, Young-Pearse T . Embryonic mosaic deletion of APP results in displaced Reelin-expressing cells in the cerebral cortex. Dev Biol. 2017; 424(2):138-146. PMC: 5411011. DOI: 10.1016/j.ydbio.2017.03.007. View

Palop J, Mucke L . Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci. 2016; 17(12):777-792. PMC: 8162106. DOI: 10.1038/nrn.2016.141. View

Hardy J, Higgins G . Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992; 256(5054):184-5. DOI: 10.1126/science.1566067. View

Mattson M, Magnus T . Ageing and neuronal vulnerability. Nat Rev Neurosci. 2006; 7(4):278-94. PMC: 3710114. DOI: 10.1038/nrn1886. View

Fanutza T, Prete D, Ford M, Castillo P, DAdamio L . APP and APLP2 interact with the synaptic release machinery and facilitate transmitter release at hippocampal synapses. Elife. 2015; 4:e09743. PMC: 4755753. DOI: 10.7554/eLife.09743. View

Benilova I, Karran E, De Strooper B . The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci. 2012; 15(3):349-57. DOI: 10.1038/nn.3028. View

Selkoe D . Alzheimer's disease is a synaptic failure. Science. 2002; 298(5594):789-91. DOI: 10.1126/science.1074069. View

Wang B, Wang Z, Sun L, Yang L, Li H, Cole A . The amyloid precursor protein controls adult hippocampal neurogenesis through GABAergic interneurons. J Neurosci. 2014; 34(40):13314-25. PMC: 4180470. DOI: 10.1523/JNEUROSCI.2848-14.2014. View

10.

Puzzo D, Piacentini R, Fa M, Gulisano W, Li Puma D, Staniszewski A . LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent. Elife. 2017; 6. PMC: 5529106. DOI: 10.7554/eLife.26991. View

11.

Wang Z, Jackson R, Hong W, Taylor W, Corbett G, Moreno A . Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP. J Neurosci. 2017; 37(49):11947-11966. PMC: 5719975. DOI: 10.1523/JNEUROSCI.2009-17.2017. View

12.

Jankowsky J, Zheng H . Practical considerations for choosing a mouse model of Alzheimer's disease. Mol Neurodegener. 2017; 12(1):89. PMC: 5741956. DOI: 10.1186/s13024-017-0231-7. View

13.

Van Cauwenberghe C, Van Broeckhoven C, Sleegers K . The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med. 2015; 18(5):421-30. PMC: 4857183. DOI: 10.1038/gim.2015.117. View

14.

Muller U, Deller T, Korte M . Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci. 2017; 18(5):281-298. DOI: 10.1038/nrn.2017.29. View